View Single Post
  #1  
Unread 08-21-2010, 11:16 PM
nmrlearner's Avatar
nmrlearner nmrlearner is offline
Senior Member
 
Join Date: Jan 2005
Posts: 23,187
Points: 193,617, Level: 100
Points: 193,617, Level: 100 Points: 193,617, Level: 100 Points: 193,617, Level: 100
Level up: 0%, 0 Points needed
Level up: 0% Level up: 0% Level up: 0%
Activity: 50.7%
Activity: 50.7% Activity: 50.7% Activity: 50.7%
Last Achievements
Award-Showcase
NMR Credits: 0
NMR Points: 0
Downloads: 0
Uploads: 0
Default Biophysical aspects of the integrated combination of cytostatic drugs with radiothera

Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 1: In vitro investigations on the kinetics of activated isophosphamide metabolites and the determination of selective properties of DNA-interstrand and DNA-protein crosslinking mechanisms using 31P-NMR spectroscopy.

Related Articles Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 1: In vitro investigations on the kinetics of activated isophosphamide metabolites and the determination of selective properties of DNA-interstrand and DNA-protein crosslinking mechanisms using 31P-NMR spectroscopy.

Strahlenther Onkol. 1991 Jul;167(7):427-33

Authors: Ulmer W

The pH dependence of the kinetics of the "activated" isophosphamide metabolites 4-hydroxy-isophosphamide, isoaldophosphamide and isophosphoramide mustard has been characterized with the help of 31P-NMR Fourier spectroscopy. The most outstanding feature is the pH-dependence of the decay kinetics of 4-hydroxy-isophosphamide and isoaldophosphamide yielding the alkylating moiety isophosphoramide mustard and acrolein. With the same spectroscopic technique the alkylation of biomolecules containing guanine (cGMP, GDP, GTP, synthetic oligodeoxynucleic acid serving as a surrogate of DNA) and proteins containing cysteine as receptor molecule have been analyzed. The kinetic data provide information on combining the measured substrates with radiotherapy to be presented in further communications.

PMID: 1858021 [PubMed - indexed for MEDLINE]



Source: PubMed
Reply With Quote


Did you find this post helpful? Yes | No